A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...
TransCode Therapeutics, Inc. RNAZ announced Wednesday that it has successfully completed the Phase 1a dose-escalation ...
Pimitespib achieved stable disease in 66.7% of patients with advanced GISTs in an expanded access program in Japan. Approved as a fourth-line treatment, pimitespib extended progression-free survival ...
Zanidatamab monotherapy significantly improves overall survival in HER2-positive advanced biliary tract cancer, reducing disease progression or death risk by 60% for responders. The HERIZON-BTC-01 ...
Patients with quiescent systemic lupus erythematosus (SLE) who are on maintenance therapy with mycophenolate mofetil (MMF) may be able to be safely weaned off the drug with the understanding that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results